Netherton SyndromeSymptoms, Doctors, Treatments, Advances & More
Netherton Syndrome Overview
Learn About Netherton Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Alain Hovnanian practices practicing medicine in Paris, France. Mr. Hovnanian is rated as an Elite expert by MediFind in the treatment of Netherton Syndrome. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Netherton Syndrome, Olmsted Syndrome, Dystrophic Epidermolysis Bullosa, and Epidermolysis Bullosa.
Wei-li Di practices practicing medicine in London, United Kingdom. Di is rated as an Elite expert by MediFind in the treatment of Netherton Syndrome. They are also highly rated in 4 other conditions, according to our data. Their clinical expertise encompasses Netherton Syndrome, Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, and Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limbs Defects.
Great Ormond Street Hospital For Children National Health Service Trust & University College London Institute Of Child Health
Waseem Qasim practices practicing medicine in London, United Kingdom. Mr. Qasim is rated as an Elite expert by MediFind in the treatment of Netherton Syndrome. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Netherton Syndrome, Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, Primary Immunodeficiency (PID), and Bone Marrow Transplant.
Summary: This is a first-in-human, Phase 1/1b, 4-part study that includes the evaluation of safety, tolerability, pharmacokinetics (PK), and immunogenicity of BCX17725 when administered via single and multiple doses in healthy adult participants (Parts 1 and 2), and multiple doses in adult participants with Netherton syndrome (Part 3). In Part 4, the effectiveness, safety, and tolerability of BCX17725 when...
Summary: The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to ATR12-351, and to observe treatment benefits of the drug in approximately 12 adult patients with Netherton Syndrome (NS). ATR12-351 will be applied to skin lesions on one side of the body, while the vehicle control will be applied to similar lesion o...